Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Maternal Zika Virus Infection: Association With Small-for-Gestational-Age Neonates and Preterm Birth.

Cooper HJ, Iwamoto M, Lash M, Conners EE, Paladini M, Slavinski S, Fine AD, Kennedy J, Heinke D, Ciaranello A, Seage GR 3rd, Lee EH.

Obstet Gynecol. 2019 Dec;134(6):1197-1204. doi: 10.1097/AOG.0000000000003577.

PMID:
31764729
2.

Correction to: International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR 3rd, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C.

BMC Pregnancy Childbirth. 2019 Nov 19;19(1):423. doi: 10.1186/s12884-019-2589-8.

3.

Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.

Williams PL, Yildirim C, Chadwick EG, Van Dyke RB, Smith R, Correia KF, DiPerna A, Seage GR 3rd, Hazra R, Crowell CS; Surveillance Monitoring for ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study.

Lancet HIV. 2019 Nov 15. pii: S2352-3018(19)30340-6. doi: 10.1016/S2352-3018(19)30340-6. [Epub ahead of print]

PMID:
31740351
4.

Maternal Zika Virus Infection: Association With Small-for-Gestational-Age Neonates and Preterm Birth.

Cooper HJ, Iwamoto M, Lash M, Conners EE, Paladini M, Slavinski S, Fine AD, Kennedy J, Heinke D, Ciaranello A, Seage GR 3rd, Lee EH.

Obstet Gynecol. 2019 Nov 4. doi: 10.1097/AOG.0000000000003577. [Epub ahead of print]

PMID:
31698388
5.

International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galvão LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR 3rd, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C.

BMC Pregnancy Childbirth. 2019 Aug 7;19(1):282. doi: 10.1186/s12884-019-2430-4. Erratum in: BMC Pregnancy Childbirth. 2019 Nov 19;19(1):423.

6.

Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Martinez DR, Fong Y, Li SH, Yang F, Jennewein MF, Weiner JA, Harrell EA, Mangold JF, Goswami R, Seage GR 3rd, Alter G, Ackerman ME, Peng X, Fouda GG, Permar SR.

Cell. 2019 Jun 27;178(1):190-201.e11. doi: 10.1016/j.cell.2019.05.046. Epub 2019 Jun 13.

7.

Botswana should consider expansion of free antiretroviral therapy to immigrants.

Escudero DJ, Marukutira T, McCormick A, Makhema J, Seage GR III.

J Int AIDS Soc. 2019 Jun;22(6):e25328. doi: 10.1002/jia2.25328. No abstract available.

8.

Disparities in HIV Viral Suppression Among Adolescents and Young Adults by Perinatal Infection.

Patel K, Seage GR 3rd, Burchett SK, Hazra R, Van Dyke RB; Pediatric HIV/AIDS Cohort Study.

Am J Public Health. 2019 Jul;109(7):e9. doi: 10.2105/AJPH.2019.305108. No abstract available.

PMID:
31166735
9.

Progress and Challenges in "Getting to Zero" New HIV Infections in Miami, Florida.

Escudero DJ, Bennett B, Suarez S, Darrow WW, Mayer KH, Seage GR 3rd.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219852122. doi: 10.1177/2325958219852122.

10.

Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.

Moscicki AB, Karalius B, Tassiopoulos K, Yao TJ, Jacobson DL, Patel K, Purswani M, Seage GR; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2019 Sep 13;69(7):1183-1191. doi: 10.1093/cid/ciy1040.

PMID:
30927547
11.

Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa.

Abuelezam NN, McCormick AW, Surface ED, Fussell T, Freedberg KA, Lipsitch M, Seage GR.

Epidemiol Infect. 2019 Jan;147:e122. doi: 10.1017/S0950268818003497.

12.

The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth.

Shiboski CH, Yao TJ, Russell JS, Ryder MI, Van Dyke RB, Seage GR 3rd, Moscicki AB; Pediatric HIV/AIDS Cohort Study.

AIDS. 2018 Nov 13;32(17):2497-2505. doi: 10.1097/QAD.0000000000001965.

13.

Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop.

Slogrove AL, Becquet R, Chadwick EG, Côté HCF, Essajee S, Hazra R, Leroy V, Mahy M, Murenga M, Wambui Mwangi J, Oyiengo L, Rollins N, Penazzato M, Seage GR 3rd, Serghides L, Vicari M, Powis KM.

Front Pediatr. 2018 May 30;6:157. doi: 10.3389/fped.2018.00157. eCollection 2018.

14.

Utility of the National Death Index in Identifying Deaths in a Clinic-Based, Multisite Cohort: The Experience of the Pediatric HIV/AIDS Cohort Study.

Alperen J, Davidson J, Siminski S, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):e37-e39. doi: 10.1097/QAI.0000000000001763. No abstract available.

15.

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

Rough K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K; PHACS and the IMPAACT P1025 Study Teams.

N Engl J Med. 2018 Apr 26;378(17):1593-1603. doi: 10.1056/NEJMoa1701666.

16.

Antiretroviral Therapy and Mortality in Rural South Africa: A Comparison of Causal Modeling Approaches.

Oldenburg CE, Seage GR, Tanser F, De Gruttola V, Mayer KH, Mimiaga MJ, Bor J, Bärnighausen T.

Am J Epidemiol. 2018 Aug 1;187(8):1772-1779. doi: 10.1093/aje/kwy065.

17.

In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.

Chaudhury S, Mayondi GK, Williams PL, Leidner J, Shapiro R, Diseko M, Ajibola G, Holding P, Tepper V, Makhema J, Petlo C, Seage GR 3rd, Lockman S, Kammerer B.

AIDS. 2018 Jun 1;32(9):1173-1183. doi: 10.1097/QAD.0000000000001790.

18.

Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa.

Oldenburg CE, Bor J, Harling G, Tanser F, Mutevedzi T, Shahmanesh M, Seage GR, De Gruttola V, Mimiaga MJ, Mayer KH, Pillay D, Bärnighausen T.

AIDS. 2018 Mar 13;32(5):635-643. doi: 10.1097/QAD.0000000000001737.

19.

Simulations for designing and interpreting intervention trials in infectious diseases.

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M.

BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3.

20.

Using Observational Data to Calibrate Simulation Models.

Murray EJ, Robins JM, Seage GR 3rd, Lodi S, Hyle EP, Reddy KP, Freedberg KA, Hernán MA.

Med Decis Making. 2018 Feb;38(2):212-224. doi: 10.1177/0272989X17738753. Epub 2017 Nov 15.

21.

Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.

Chaudhury S, Williams PL, Mayondi GK, Leidner J, Holding P, Tepper V, Nichols S, Magetse J, Sakoi M, Moabi K, Makhema J, Mdluli C, Jibril H, Seage GR 3rd, Kammerer B, Lockman S.

Pediatrics. 2017 Oct;140(4). pii: e20170988. doi: 10.1542/peds.2017-0988. Epub 2017 Sep 14.

22.

A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.

Murray EJ, Robins JM, Seage GR, Freedberg KA, Hernán MA.

Am J Epidemiol. 2017 Jul 15;186(2):131-142. doi: 10.1093/aje/kwx091.

23.

Zidovudine use in pregnancy and congenital malformations.

Rough K, Sun JW, Seage GR 3rd, Williams PL, Huybrechts KF, Bateman BT, Hernandez-Diaz S.

AIDS. 2017 Jul 31;31(12):1733-1743. doi: 10.1097/QAD.0000000000001549. Review.

24.

Displacement of sexual partnerships in trials of sexual behavior interventions: A model-based assessment of consequences.

McCormick AW, Abuelezam NN, Fussell T, Seage GR 3rd, Lipsitch M.

Epidemics. 2017 Sep;20:94-101. doi: 10.1016/j.epidem.2017.03.007. Epub 2017 Apr 2.

25.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration; Centers for AIDS Research Network of Integrated Clinical Systems.

Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.

26.

Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Neilan AM, Karalius B, Patel K, Van Dyke RB, Abzug MJ, Agwu AL, Williams PL, Purswani M, Kacanek D, Oleske JM, Burchett SK, Wiznia A, Chernoff M, Seage GR 3rd, Ciaranello AL; Pediatric HIV/AIDS Cohort Study and the International Maternal Adolescent and Pediatric AIDS Clinical Trials Network.

JAMA Pediatr. 2017 May 1;171(5):450-460. doi: 10.1001/jamapediatrics.2017.0141.

27.

Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.

Uprety P, Patel K, Karalius B, Ziemniak C, Chen YH, Brummel SS, Siminski S, Van Dyke RB, Seage GR, Persaud D; Pediatric HIV/AIDS Cohort Study (PHACS) .

Clin Infect Dis. 2017 Jun 1;64(11):1471-1478. doi: 10.1093/cid/cix192. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

28.

Reply to Cohen et al.

Oldenburg CE, Bärnighausen T, Tanser F, Iwuji CC, De Gruttola V, Seage GR 3rd, Mimiaga MJ, Mayer KH, Pillay D, Harling G.

Clin Infect Dis. 2016 Dec 15;63(12):1680. Epub 2016 Sep 29. No abstract available.

29.

Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children.

Spector SA, Brummel SS, Nievergelt CM, Maihofer AX, Singh KK, Purswani MU, Williams PL, Hazra R, Van Dyke R, Seage GR 3rd; Pediatric HIVAIDS Cohort Study (PHACS).

Medicine (Baltimore). 2016 Sep;95(36):e4733. doi: 10.1097/MD.0000000000004733.

30.

Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.

Abuelezam NN, McCormick AW, Fussell T, Afriyie AN, Wood R, DeGruttola V, Freedberg KA, Lipsitch M, Seage GR 3rd.

Am J Epidemiol. 2016 Aug 1;184(3):239-48. doi: 10.1093/aje/kwv344. Epub 2016 Jul 13.

31.

The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.

Moscicki AB, Yao TJ, Ryder MI, Russell JS, Dominy SS, Patel K, McKenna M, Van Dyke RB, Seage GR 3rd, Hazra R; Shiboski.

PLoS One. 2016 Jun 14;11(6):e0156459. doi: 10.1371/journal.pone.0156459. eCollection 2016.

32.

Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study.

Tassiopoulos K, Patel K, Alperen J, Kacanek D, Ellis A, Berman C, Allison SM, Hazra R, Barr E, Cantos K, Siminski S, Massagli M, Bauermeister J, Siddiqui DQ, Puga A, Van Dyke R, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study.

BMJ Open. 2016 Jun 9;6(6):e011396. doi: 10.1136/bmjopen-2016-011396.

33.

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs.

Van Dyke RB, Chadwick EG, Hazra R, Williams PL, Seage GR 3rd.

Front Immunol. 2016 May 23;7:199. doi: 10.3389/fimmu.2016.00199. eCollection 2016. Review.

34.

Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.

Oldenburg CE, Bärnighausen T, Tanser F, Iwuji CC, De Gruttola V, Seage GR 3rd, Mimiaga MJ, Mayer KH, Pillay D, Harling G.

Clin Infect Dis. 2016 Aug 15;63(4):548-54. doi: 10.1093/cid/ciw335. Epub 2016 May 20.

35.

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Van Dyke RB, Patel K, Kagan RM, Karalius B, Traite S, Meyer WA 3rd, Tassiopoulos KK, Seage GR 3rd, Seybolt LM, Burchett S, Hazra R; Pediatric HIV/AIDS Cohort Study (PHACS), Lurie RH, Yogev R, Sanders MA, Malee K, Hunter S, Shearer W, Paul M, Cooper N, Harris L, Purswani M, Baig M, Cintron A, Puga A, Navarro S, Garvie P, Blood J, Burchett S, Karthas N, Kammerer B, Wiznia A, Burey M, Nozyce M, Dieudonne A, Bettica L, Adubato S, Chen J, Bulkley MG, Ivey L, Grant M, Knapp K, Allison K, Wilkins M, Acevedo-Flores M, Rios H, Olivera V, Silio M, Jones M, Sirois P, Spector S, Norris K, Nichols S, McFarland E, Katai A, Dunn J, Paul S, Scott G, Bryan P, Willen E.

Clin Infect Dis. 2016 Jul 1;63(1):133-137. doi: 10.1093/cid/ciw213. Epub 2016 Apr 7.

36.

Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection.

Purswani MU, Patel K, Winkler CA, Spector SA, Hazra R, Seage GR 3rd, Mofenson L, Karalius B, Scott GB, Van Dyke RB, Kopp JB; Pediatric HIVAIDS Cohort Study.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):63-8. doi: 10.1097/QAI.0000000000001010.

37.

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.

Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Olson A, Justice AC, Tate JP, Bucher HC, Egger M, Touloumi G, Sterne JA, Costagliola D, Saag M, Hernán MA; Center for AIDS Research Network of Integrated Clinical Systems and the HIV-CAUSAL Collaboration.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):214-21. doi: 10.1097/QAI.0000000000000956.

38.

Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.

Caniglia EC, Patel K, Huo Y, Williams PL, Kapetanovic S, Rich KC, Sirois PA, Jacobson DL, Hernandez-Diaz S, Hernán MA, Seage GR 3rd; Pediatric HIVAIDS Cohort Study.

AIDS. 2016 May 15;30(8):1267-78. doi: 10.1097/QAD.0000000000001052.

39.

Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.

Williams PL, Hazra R, Van Dyke RB, Yildirim C, Crain MJ, Seage GR 3rd, Civitello L, Ellis A, Butler L, Rich K; Pediatric HIV/AIDS Cohort Study.

AIDS. 2016 Jan 2;30(1):133-44. doi: 10.1097/QAD.0000000000000916.

40.

Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana.

Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR 3rd, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S.

PLoS One. 2015 Sep 16;10(9):e0138742. doi: 10.1371/journal.pone.0138742. eCollection 2015. No abstract available.

41.

Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.

Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, Oleske JM, Purswani MU, Hazra R, Traite S, Zimmer B, Van Dyke RB; IMPAACT P1074 Study Team.

Clin Infect Dis. 2015 Dec 15;61(12):1850-61. doi: 10.1093/cid/civ687. Epub 2015 Aug 12.

42.

Cancer Incidence following Expansion of HIV Treatment in Botswana.

Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR 3rd, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S.

PLoS One. 2015 Aug 12;10(8):e0135602. doi: 10.1371/journal.pone.0135602. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138742.

43.

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.

Fairlie L, Karalius B, Patel K, van Dyke RB, Hazra R, Hernán MA, Siberry GK, Seage GR 3rd, Agwu A, Wiznia A; Pediatric HIV AIDS Cohort Study (PHACS), The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT).

AIDS. 2015 Oct 23;29(16):2109-19. doi: 10.1097/QAD.0000000000000809.

44.

Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero.

Marsit CJ, Brummel SS, Kacanek D, Seage GR 3rd, Spector SA, Armstrong DA, Lester BM, Rich K; Pediatric HIV/AIDS Cohort Studies Network.

Epigenetics. 2015;10(8):708-16. doi: 10.1080/15592294.2015.1060389.

45.

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Siberry GK, Jacobson DL, Kalkwarf HJ, Wu JW, DiMeglio LA, Yogev R, Knapp KM, Wheeler JJ, Butler L, Hazra R, Miller TL, Seage GR 3rd, Van Dyke RB, Barr E, Davtyan M, Mofenson LM, Rich KC; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2015 Sep 15;61(6):996-1003. doi: 10.1093/cid/civ437. Epub 2015 Jun 9.

46.

CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users.

Anderson JP, Horsburgh CR Jr, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR 3rd.

Open Forum Infect Dis. 2015 Feb 28;2(1):ofv019. doi: 10.1093/ofid/ofv019. eCollection 2015 Jan.

47.

The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.

Nieves CI, Kaida A, Seage GR 3rd, Kabakyenga J, Muyindike W, Boum Y, Mocello AR, Martin JN, Hunt PW, Haberer JE, Bangsberg DR, Matthews LT.

Contraception. 2015 Aug;92(2):152-9. doi: 10.1016/j.contraception.2015.04.011. Epub 2015 May 14.

48.

Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.

Phiri K, Williams PL, Dugan KB, Fischer MA, Cooper WO, Seage GR 3rd, Hernandez-Diaz S.

Pediatr Infect Dis J. 2015 Jul;34(7):e169-75. doi: 10.1097/INF.0000000000000712.

49.

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.

Krogstad P, Patel K, Karalius B, Hazra R, Abzug MJ, Oleske J, Seage GR 3rd, Williams PL, Borkowsky W, Wiznia A, Pinto J, Van Dyke RB; Pediatric HIVAIDS Cohort Study, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI) Investigators.

AIDS. 2015 Mar 27;29(6):683-93. doi: 10.1097/QAD.0000000000000598.

50.

Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Rough K, Tassiopoulos K, Kacanek D, Griner R, Yogev R, Rich KC, Seage GR 3rd; Pediatric HIVAIDS Cohort Study.

AIDS. 2015 Jan 2;29(1):117-23. doi: 10.1097/QAD.0000000000000503.

Supplemental Content

Loading ...
Support Center